Ipamorelin

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that selectively stimulates the pituitary gland to release natural growth hormone (GH) by binding to ghrelin receptors.

It is widely regarded as one of the most selective and well-tolerated peptides in its class because it significantly increases GH and insulin-like growth factor 1 (IGF-1) levels without elevating cortisol, prolactin, or other stress hormones, distinguishing it from older GHRPs like GHRP-6.

Common therapeutic goals and observed benefits include improved sleep quality (particularly deep and REM sleep), enhanced recovery from physical exertion, increased lean muscle mass, and accelerated fat loss, especially in the abdominal region.

Users often report better skin elasticity, joint health, and sustained energy levels, with initial improvements in sleep and recovery typically appearing within 2–4 weeks and body composition changes becoming evident after 8–12 weeks of consistent use.

Regarding safety and administration, ipamorelin is generally considered safe when prescribed by a qualified clinician, monitored with regular labs, and dosed appropriately (commonly 200–300 mcg via subcutaneous injection once or twice daily). While serious adverse effects are uncommon, potential side effects include temporary fatigue, headache, flushing, or increased hunger. It is important to note that ipamorelin is not FDA-approved for human clinical use and is currently marketed primarily as a research peptide or through compounding pharmacies, with usage prohibited in competitive sports under anti-doping regulations.